UNDA 270 (Seroyal USA)
Welcome to the PulseAid listing for the UNDA 270 drug offered from Seroyal USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Seroyal USA |
| NON-PROPRIETARY NAME: | Equisetum arvense, Hypericum perforatum |
| SUBSTANCE NAME: | HYPERICUM PERFORATUM; EQUISETUM ARVENSE TOP |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2015-06-01 |
| END MARKETING DATE: | 0000-00-00 |
UNDA 270 HUMAN OTC DRUG Details:
| Item Description | UNDA 270 from Seroyal USA |
| LABELER NAME: | Seroyal USA |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1; 1([hp_X]/40g; [hp_X]/40g) |
| START MARKETING DATE: | 2015-06-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 62106-0097_5abbb3c6-660c-4176-e053-2991aa0aeff8 |
| PRODUCT NDC: | 62106-0097 |
| APPLICATION NUMBER: | |
Other HYPERICUM PERFORATUM; EQUISETUM ARVENSE TOP Pharmaceutical Manufacturers / Labelers:
